Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1961 Aug 5;85(6):295–298.

A Preliminary Report of the Anti-Inflammatory Effect of Oxyphenbutazone (G27202) In Postoperative Obstetrical and Gynecological Practice *

W Dennis Fraser, Peter J Beardall, George B Maughan
PMCID: PMC1848233  PMID: 13701531

Full text

PDF
295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CARDOE N. Controlled trial of G27 202 (p-hydroxyphenyl-butazone) in rheumatoid arthritis. Ann Rheum Dis. 1959 Sep;18:244–248. doi: 10.1136/ard.18.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. HART F. D., BURLEY D. Phenylbutazone and its derivatives with special reference to G.27202. Br Med J. 1959 Apr 25;1(5129):1087–1089. doi: 10.1136/bmj.1.5129.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hodgetts C. A. INFANTILE MORTALITY IN CANADA. Can Med Assoc J. 1911 Aug;1(8):720–729. [PMC free article] [PubMed] [Google Scholar]
  4. PENT D., ROJAS J. Compound G-27202 in the treatment of thrombophlebitis. Obstet Gynecol. 1960 Aug;16:206–209. [PubMed] [Google Scholar]
  5. VAUGHN P. P., HOWELL D. S., KIEM I. M. The comparative effects of phenylbutazone and G27202 (metabolite I) in patients with rheumatoid arthritis: an assessment of methods for antirheumatic drug evaluation. Arthritis Rheum. 1959 Jun;2(3):212–223. doi: 10.1002/1529-0131(195906)2:3<212::aid-art1780020304>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  6. WILHELMI G. [Pharmacological properties of the metabolites of 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazolidine]. Arzneimittelforschung. 1960 Feb;10:129–133. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES